These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15448668)

  • 1. Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity - a single center study from Singapore.
    Enjeti AK; Tien SL; Sivaswaren CR
    Hematol J; 2004; 5(5):419-25. PubMed ID: 15448668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
    Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.
    Gmidène A; Sennana H; Wahchi I; Youssef YB; Jeddi R; Elloumi M; Saad A
    Hematology; 2012 Jan; 17(1):9-14. PubMed ID: 22549442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
    Grimwade D; Walker H; Oliver F; Wheatley K; Harrison C; Harrison G; Rees J; Hann I; Stevens R; Burnett A; Goldstone A
    Blood; 1998 Oct; 92(7):2322-33. PubMed ID: 9746770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.
    Fröhling S; Skelin S; Liebisch C; Scholl C; Schlenk RF; Döhner H; Döhner K;
    J Clin Oncol; 2002 May; 20(10):2480-5. PubMed ID: 12011125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.
    Cheng Y; Wang Y; Wang H; Chen Z; Lou J; Xu H; Wang H; Qian W; Meng H; Lin M; Jin J
    Leukemia; 2009 Oct; 23(10):1801-6. PubMed ID: 19474801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia.
    Joventino LP; Stock W; Lane NJ; Daly KM; Mick R; Le Beau MM; Larson RA
    Leukemia; 1995 Mar; 9(3):433-9. PubMed ID: 7885042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study.
    Byun JM; Kim YJ; Yoon HJ; Kim SY; Kim HJ; Yoon J; Min YH; Cheong JW; Park J; Lee JH; Hong DS; Park SK; Kim HJ; Ahn JS; Shin HJ; Chung JS; Lee WS; Lee SM; Park Y; Kim BS; Lee JH; Lee KH; Jung CW; Jang JH; Min WS; Park TS;
    Ann Hematol; 2016 Aug; 95(8):1223-32. PubMed ID: 27230620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics in acute myeloid leukaemia.
    Walker H; Smith FJ; Betts DR
    Blood Rev; 1994 Mar; 8(1):30-6. PubMed ID: 8205008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
    Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
    Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
    Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
    Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
    Creutzig U; Zimmermann M; Reinhardt D; Rasche M; von Neuhoff C; Alpermann T; Dworzak M; Perglerová K; Zemanova Z; Tchinda J; Bradtke J; Thiede C; Haferlach C
    Cancer; 2016 Dec; 122(24):3821-3830. PubMed ID: 27529519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
    Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
    Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.